May 8, 2026 – The U.S. Food and Drug Administration (FDA) on Wednesday acknowledged ongoing supply disruptions of neurosurgical patties, sponges and strips, and warned that the shortage could last through the end of 2026.
In March, Medline Industries recalled neurosurgical patties in its neuro sponge line over elevated endotoxin levels, with no return date set, the FDA said.
Healthcare service provider Premier said the recalled products are highly specialized for brain and spine surgeries. “This is a high-risk low-frequency product,” said Karen Niven, senior director of clinical value analysis at Premier. “We have advised our members to first look at conservation.”
The FDA said it is working with other manufacturers and healthcare providers to monitor supplies and evaluate ways to reduce the impact on patients.